Search Results for compound
Searching compound for 3 hydroxynicotine acid returned 62915 results.
Displaying compounds 22201 - 22225 of 62915 in total
FDB011397
9004-65-3
2-({6-[(6-{[4,5-dihydroxy-2-(hydroxymethyl)-6-methoxyoxan-3-yl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl)oxy]-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol
Matched iupac: … -3-yl)oxy]-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol ... 2-({6-[(6-{[4,5-dihydroxy-2-(hydroxymethyl)-6-methoxyoxan-3-yl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan …
Matched description: … sites of substitution with each cellulose molecule, this average value is a real number between 0 and 3. …
Matched description: … sites of substitution with each cellulose molecule, this average value is a real number between 0 and 3. …
FDB020188
93-04-9
FDB008548
93-15-2
1,2-dimethoxy-4-(prop-2-en-1-yl)benzene
Matched synonyms: … 1-(3, 4-Dimethoxyphenyl)-2-propene …
(2R,3R,4S,5R)-oxane-2,3,4,5-tetrol
Matched description: … including galactose, glucose, mannose, N-acetylglucosamine, N-acetylgalactosamine, fucose, and sialic acid …
FDB008105
497-03-0
FDB024008
98359-76-3
N-[(2R,3R,4R,5S,6R)-2-{[(3S,5R,6S)-3,5-dihydroxy-4-{[(2S,3R,4R,5S,6R)-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)-4-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-{[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-6-{[(2R,3R,4R,5R)-1,2,4,5-tetrahydroxy-6-oxohexan-3-yl]oxy}oxan-2-yl]methoxy}-6-(hydroxymethyl)-5-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4-{[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-3-yl]ethanimidic acid
Matched iupac: … yl]ethanimidic acid ... N-[(2R,3R,4R,5S,6R)-2-{[(3S,5R,6S)-3,5-dihydroxy-4-{[(2S,3R,4R,5S,6R)-3-[(1-hydroxyethylidene)amino]- ... 3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-6-{[(2R,3R,4R,5R)-1,2,4,5-tetrahydroxy-6-oxohexan-3- ... trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4-{[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-3- …
Matched description: … monosaccharidic units represented by fucose (Fuc), galactose (Gal), N-acetylglucosamine (GlcNac) and sialic acid …
Matched description: … monosaccharidic units represented by fucose (Fuc), galactose (Gal), N-acetylglucosamine (GlcNac) and sialic acid …
FDB015151
20972-07-0
14-(5,6-dimethylheptan-2-yl)-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-7-en-5-yl (2Z)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
Matched iupac: … -3-methoxyphenyl)prop-2-enoate ... 14-(5,6-dimethylheptan-2-yl)-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-7-en-5-yl (2Z)-3-(4-hydroxy …
Matched description: … Magnesium also reacts exothermically with most acids, such as hydrochloric acid (HCl). ... As with aluminium, zinc and many other metals, the reaction with hydrochloric acid produces the chloride ... Magnesium citrate has been reported as more bioavailable than oxide or amino-acid chelate (glycinate) …
Matched description: … Magnesium also reacts exothermically with most acids, such as hydrochloric acid (HCl). ... As with aluminium, zinc and many other metals, the reaction with hydrochloric acid produces the chloride ... Magnesium citrate has been reported as more bioavailable than oxide or amino-acid chelate (glycinate) …
FDB005174
86050-77-3
gadolinium(3+) ion bis((2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol) 2-[bis({2-[(carboxylatomethyl)(carboxymethyl)amino]ethyl})amino]acetate
Matched iupac: … gadolinium(3+) ion bis((2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol) 2-[bis({2-[(carboxylatomethyl …
Matched description: … Gadopentetate dimeglumine, also known as gadopentetic acid dimeglumine salt or magnevist, belongs to ... Gadopentetic acid is one of the trade names for a gadolinium-based MRI contrast agent, usually administered …
Matched description: … Gadopentetate dimeglumine, also known as gadopentetic acid dimeglumine salt or magnevist, belongs to ... Gadopentetic acid is one of the trade names for a gadolinium-based MRI contrast agent, usually administered …
FDB007353
26002-80-2
(3-phenoxyphenyl)methyl 2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropane-1-carboxylate
Matched iupac: … (3-phenoxyphenyl)methyl 2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropane-1-carboxylate …
Matched description: … Some pyrethroids containing a chrysanthemic acid esterified with a cyclopentenone (pyrethrins), or with …
Matched description: … Some pyrethroids containing a chrysanthemic acid esterified with a cyclopentenone (pyrethrins), or with …
FDB010869
83-70-5
4-amino-2-methylnaphthalen-1-ol
Matched synonyms: … 4-Hydroxy-3-methyl-1-naphthylammonium chloride …
(2E)-hex-2-enal
Matched description: … 2-Hexenal, also known as 2-hexenaldehyde, 3-propyl-acrolein or leaf aldehyde, belongs to the class of …
FDB021787
3646-73-9
(2S,3R,4S,5R,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol
Matched description: … Glucose-1-phosphate will then enter the glycolytic pathway for energy production. 3) UDP-galactose epimerase …
FDB007124
1088-11-5
7-chloro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one
Matched synonyms: … 2H-1,4-Benzodiazepin-2-one, 1, 3-dihydro-7-chloro-5-phenyl- ... 7-Chloro-1, 3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one …
N-(3-hydroxy-1-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadec-4-en-2-yl)tetracos-15-enamide
Matched iupac: … N-(3-hydroxy-1-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadec-4-en-2-yl)tetracos …
Matched description: … Symptoms begin between the ages of 3 and 6 months with irritability, fevers, limb stiffness, seizures …
Matched description: … Symptoms begin between the ages of 3 and 6 months with irritability, fevers, limb stiffness, seizures …
N-(3-hydroxy-1-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadec-4-en-2-yl)icosanamide
Matched iupac: … N-(3-hydroxy-1-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadec-4-en-2-yl)icosanamide …
Matched description: … Symptoms begin between the ages of 3 and 6 months with irritability, fevers, limb stiffness, seizures …
Matched description: … Symptoms begin between the ages of 3 and 6 months with irritability, fevers, limb stiffness, seizures …
FDB028943
148347-41-5
N-(3-hydroxy-1-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadec-4-en-2-yl)tetradecanamide
Matched iupac: … N-(3-hydroxy-1-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadec-4-en-2-yl)tetradecanamide …
Matched description: … Symptoms begin between the ages of 3 and 6 months with irritability, fevers, limb stiffness, seizures …
Matched description: … Symptoms begin between the ages of 3 and 6 months with irritability, fevers, limb stiffness, seizures …
FDB012589
124-40-3
dimethylamine
Matched description: … In the body, DMA also undergoes nitrosation under weak acid conditions to give dimethlynitrosamine. …
FDB030832
14000-31-8
(phosphonooxy)phosphonate
Matched description: … Pyrophosphate, also known as diphosphoric acid or ppi, is a member of the class of compounds known as …
FDB011663
479-13-0
5,14-dihydroxy-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-1(10),2(7),3,5,11,13,15-heptaen-9-one
Matched synonyms: … 6',7-Dihydroxybenzofuro[3',2',3,4]coumarin (obsol.) …
FDB011930
431-03-8
FDB022940
1218-98-0
2-amino-6-(1,2,3-trihydroxypropyl)-1,4,7,8-tetrahydropteridin-4-one
Matched synonyms: … 2-Amino-4-hydroxy-6-(D-erythro-1',2',3'-trihydroxypropyl)-7,8-dihydropteridine …
FDB015360
6753-98-6
(1Z,4Z,8Z)-2,6,6,9-tetramethylcycloundeca-1,4,8-triene
Matched description: … The biosynthesis of sesquiterpenes is known to occur mainly through the mevalonic acid pathway (MVA; …
FDB020487
143363-61-5
6-{[5-({3,4-dihydroxy-6-methyl-5-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl}oxy)-3,4-dihydroxy-6-({2-methyl-1-[5-methyl-2-(prop-1-en-2-yl)cyclohexa-1,5-dien-1-yl]but-3-en-2-yl}oxy)oxan-2-yl]methoxy}-4,5-dihydroxy-2-methyloxan-3-yl (2Z)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
Matched synonyms: … 10x)-9,10-Didehydroisohumbertiol O-[a-L-rhamnopyranosyl-(1->4)-a-L-rhamnopyranosyl-(1->2)-[(4-hydroxy-3- …
Matched iupac: … en-2-yl}oxy)oxan-2-yl]methoxy}-4,5-dihydroxy-2-methyloxan-3-yl (2Z)-3-(4-hydroxy-3-methoxyphenyl)prop ... oxan-2-yl}oxy)-3,4-dihydroxy-6-({2-methyl-1-[5-methyl-2-(prop-1-en-2-yl)cyclohexa-1,5-dien-1-yl]but-3- …
Matched iupac: … en-2-yl}oxy)oxan-2-yl]methoxy}-4,5-dihydroxy-2-methyloxan-3-yl (2Z)-3-(4-hydroxy-3-methoxyphenyl)prop ... oxan-2-yl}oxy)-3,4-dihydroxy-6-({2-methyl-1-[5-methyl-2-(prop-1-en-2-yl)cyclohexa-1,5-dien-1-yl]but-3- …
N-(3-hydroxy-1-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadec-4-en-2-yl)hexadecanamide
Matched iupac: … N-(3-hydroxy-1-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadec-4-en-2-yl)hexadecanamide …
Matched description: … Symptoms begin between the ages of 3 and 6 months with irritability, fevers, limb stiffness, seizures …
Matched description: … Symptoms begin between the ages of 3 and 6 months with irritability, fevers, limb stiffness, seizures …